title: Comment: Outcomes of migraine therapy with IV dihydroergotamine.
authors: From the David Geffen School of Medicine, UCLA, Los Angeles, CA.
authors: Andrew
authors: A
authors: Charles
mesh_terms: D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006261:Headache / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D004087:Dihydroergotamine